Skip Navigation
Skip to contents

J Korean Soc Radiol.  2019 Sep;80(5):849-859. 10.3348/jksr.2019.80.5.849.

Lung Cancer Screening with Low-Dose CT: Current Status in Other Countries

Affiliations
  • 1Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. jmgoo@plaza.snu.ac.kr
  • 2Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Korea.

Abstract

Lung cancer is the leading cause of death from cancer worldwide. The most effective way to reduce lung cancer mortality is early detection and treatment. Two large randomized controlled trials (RCTs), the National Lung Screening Trial and the Dutch-Belgian Randomized Lung Cancer Screening Trial, showed that low-dose CT (LDCT) can reduce the chances of lung cancer death. This paper reviews the two aforementioned RCTs and the current situations of implementing LDCT screening in several counties. Although nationwide programs of lung cancer screening are rare, they would increase in the near future. Using the two aforementioned RCTs and accumulating data from many counties, including the East Asian countries, a more effective way of LDCT screening in Korea can be devised and implemented.


MeSH Terms

Asian Continental Ancestry Group
Cause of Death
Early Detection of Cancer
Humans
Korea
Lung Neoplasms*
Lung*
Mass Screening*
Mortality
Multidetector Computed Tomography
Tomography, X-Ray Computed*
Full Text Links
  • JKSR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr